Informações:
Falhas:
ID
21190
Descrição
Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427); ODM derived from: https://clinicaltrials.gov/show/NCT00724854
Link
https://clinicaltrials.gov/show/NCT00724854
Palavras-chave
Versões (1)
- 12/04/2017 12/04/2017 -
Transferido a
12 de abril de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C, Chronic NCT00724854
Eligibility Hepatitis C, Chronic NCT00724854
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT00724854
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Study participation status and informed consent
Item
willing to participate in the study and sign the informed consent form
boolean
C2348568 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])
HCV PCR
Item
established hcv infection, confirmed by molecular biology test (positive qualitative polymerase chain reaction [pcr] test)
boolean
C0220847 (UMLS CUI [1,1])
C0032520 (UMLS CUI [1,2])
C0032520 (UMLS CUI [1,2])
Treatment, HIV coinfection
Item
can be treatment-naïve, have retreatment, or co-infected with hiv
boolean
C0087111 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
C4062778 (UMLS CUI [2])
Pegintron and Ribavirin
Item
be under treatment with pegintron in combination with ribavirin, starting up to 14 days before the screening visit
boolean
C1527737 (UMLS CUI [1,1])
C0035525 (UMLS CUI [1,2])
C0035525 (UMLS CUI [1,2])
Study participation status
Item
participants who have not confirmed their willingness to participate in the study or have refused to sign the free and informed consent form
boolean
C2348568 (UMLS CUI [1])
Prior treatment with pegintron
Item
prior treatment with pegintron (combined with ribavirin or not)
boolean
C1514463 (UMLS CUI [1,1])
C1527737 (UMLS CUI [1,2])
C1527737 (UMLS CUI [1,2])
Substance Use Disorder
Item
history of alcohol abuse in the past 6 months
boolean
C0038586 (UMLS CUI [1])
Liver disease
Item
decompensated liver disease
boolean
C0023895 (UMLS CUI [1])
Heart disease
Item
severe heart disease
boolean
C0018799 (UMLS CUI [1])
Thyroid disorder
Item
decompensated thyroid disorder
boolean
C0040128 (UMLS CUI [1])
Neoplasia
Item
neoplasia
boolean
C1882062 (UMLS CUI [1])
Diabetes mellitus type 1
Item
type 1 diabetes mellitus - uncontrolled or hardly controlled
boolean
C0011854 (UMLS CUI [1])
Seizures
Item
seizures - uncontrolled
boolean
C0036572 (UMLS CUI [1])
Primary immune deficiency
Item
primary immune deficiency
boolean
C0398686 (UMLS CUI [1])
Contraceptive methods
Item
men and women not using appropriate contraceptive methods
boolean
C0700589 (UMLS CUI [1])
Gynaecological status
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
HIV Coinfection: HIV-related opportunistic disease or CD4 count
Item
for participants co-infected with hiv: hiv-related opportunistic disease in the past 6 months or cd4 count lower than 200 cells/mm^3
boolean
C4062778 (UMLS CUI [1])
C0162526 (UMLS CUI [2])
C0243009 (UMLS CUI [3])
C0162526 (UMLS CUI [2])
C0243009 (UMLS CUI [3])